Effect and safety of tamsulosin, the prostate specific alpha(1)-blocker, in the treatment of BPH (benign prostatic hyperplasia)

被引：2
|
作者：
Kawabe, K
机构：
[1] Department of Urology, Faculty of Medicine, The University of Tokyo, Tokyo
来源：
AKTUELLE UROLOGIE | 1996年 / 27卷
关键词：
BPH; alpha-blocker; alpha(1a)-receptor-subtype; tamsulosin;
D O I：
10.1055/s-2008-1055642
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Clinical trials of tamsulosin demonstrate that it is an effective treatment modality for the symptoms associated with BPH, and it has practically no effect on blood pressure at a dose of 0.2 mg. This is probably due to its selective affinity for the prostate, which may be due to the strong affinity of tamsulosin for the alpha(1a)-receptor subtype.
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [21] Herbal medications in the treatment of benign prostatic hyperplasia (BPH)
    Fagelman, E
    Lowe, FC
    UROLOGIC CLINICS OF NORTH AMERICA, 2002, 29 (01) : 23 - +
  • [22] Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
    Sciacqua, L. V.
    Vanzulli, A.
    Di Meo, R.
    Pellegrino, G.
    Lavorato, R.
    Vitale, G.
    Carrafiello, G.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [23] Prostatic artery embolization (PAE) for benign prostatic hyperplasia (BPH): efficacy and safety at 1 year
    Chiu, P. K.
    Kwok, K. Y.
    Yee, C. H.
    Teoh, J. Y.
    Sy, L. I.
    Kwok, S. W.
    Cho, C. C. M.
    Hung, E. H. Y.
    Ng, C. F.
    Yu, S. C. H.
    BJU INTERNATIONAL, 2019, 123 : 5 - 5
  • [24] Re: Treatment Patterns in Alpha-Blocker Therapy for Benign Prostatic Hyperplasia
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2015, 193 (05): : 1593 - 1594
  • [25] PROSTATE-SPECIFIC DELETION OF CDH1 IN MICE MIMICS PROSTATIC PERFUSION OF BENIGN PROSTATIC HYPERPLASIA (BPH) PATIENTS
    Tyagi, Pradeep
    Pascal, Laura
    Foley, Lesley
    Frederick, Robin
    Hitchens, T. Kevin
    Kanai, Anthony
    Yoshimura, Naoki
    Wang, Zhou
    JOURNAL OF UROLOGY, 2021, 206 : E201 - E202
  • [26] Transurethral Ultrasound Ablation for Treatment of Localized Prostate Cancer and Benign Prostatic Hyperplasia (BPH)
    Engelage, Lucas
    Muschter, Rolf
    JOURNAL OF ENDOUROLOGY, 2025, 39 : S23 - S26
  • [27] Prostate Artery Embolization (PAE) with Small Beads for the Treatment of Benign Prostatic Hyperplasia (BPH)
    Xhepa, Genti
    Sciacqua, Lucilla Violetta
    Vanzulli, Andrea
    Cani, Andrea Enzo
    Ascenti, Velio
    Ricoeur, Alexis
    Ianniello, Andrea Antonio
    Inzerillo, Agostino
    Nicotera, Paolo
    Del Grande, Filippo
    Ierardi, Anna Maria
    Carrafiello, Gianpaolo
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (06):
  • [28] Superiority of Dutasteride 0.5 mg and Tamsulosin 0.2 mg for the Treatment of Benign Prostatic Hyperplasia (BPH) in Asian Subjects
    Palacios, Juan Manuel
    Masumori, Naoya
    Haque, Nazneen Mahfooz
    Sakamoto, Sadaaki
    Ye, Zhangqun
    Yoon, Sang-Jin
    Kuo, Hann-Chorng
    Brotherton, Betsy
    Wilson, Timothy
    Muganurmath, Chandra
    Mclaughlin, Megan
    Manyak, Michael
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 274 - 274
  • [29] Effect of terazosin on prostate cell proliferation and apoptosis in patients with benign prostatic hyperplasia (BPH)
    Chon, JK
    Isaacs, JT
    Borkowski, A
    Partin, AW
    Kyprianou, N
    JOURNAL OF UROLOGY, 1998, 159 (05): : 106 - 106
  • [30] Alfuzosin (Uroxatral) -: Another alpha1-blocker for benign prostatic hyperplasia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2004, 46 (1173): : 1 - 2
12345